GeoVax_logo_hi-res-white-background-400x400.png
GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
December 09, 2024 09:00 ET | GeoVax, Inc.
Adds to Growing Portfolio of Intellectual Property Assets ATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and...